Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans
- 30 June 1986
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 89 (3) , 388-391
- https://doi.org/10.1007/bf00174380
Abstract
To further evaluate the effects and mechanism of action of the putative serotonin agonist m-chlorophenylpiperazine (m-CPP) in humans, changes in plasma prolactin, cortisol, growth hormone, ACTH and body temperature were studied in a group of 10 healthy volunteers following oral administration of m-CPP (0.75 mg/kg), before and after pretreatment with the serotonin receptor antagonist metergoline (MTG). M-CPP produced transient significant increases in plasma prolactin, cortisol, ACTH and in body temperature, but did not significantly alter plasma growth hormone concentration. Moreover, pretreatment with the 5HT antagonist metergoline blocked the m-CPP-induced hormonal and temperature changes. These findings provide strong support for m-CPP's effects in humans being mediated through an interaction with 5HT receptors, and thus support the usefulness of m-CPP as a pharmacologic tool for studying disease and drug-induced alterations in serotonin function in man.This publication has 25 references indexed in Scilit:
- The Corticotropin-Releasing Factor Stimulation TestNew England Journal of Medicine, 1984
- Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsibility in depressionLife Sciences, 1984
- Depending on the Stimulus, Central Serotoninergic Activation by Fenfluramine Blocks or Does not Alter Growth Hormone Secretion in ManNeuroendocrinology, 1984
- Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeysLife Sciences, 1983
- Enhanced serum cortisol response to 5-hydroxytryptophan in depression and maniaLife Sciences, 1983
- Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodoneJournal of Pharmacy and Pharmacology, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Disposition and pharmacological effects of m-Chlorophenylpiperazine in ratsNeuropharmacology, 1981
- Endocrine Profile and Therapeutic Employment of a New Prolactin-Lowering Drug, MetergolineGynecologic and Obstetric Investigation, 1980
- 1-Methyl-8 β-carbobenzyloxy-aminomethyl-10 α-ergoline, a Potent and Long-lasting 5-Hydroxytryptamine AntagonistNature, 1965